Home

Category: NP

Joint Statement on Long-Term Care – Authorized Prescriptions

There have been several questions and requests for clarification in follow up to the Long-Term Care – Authorized Prescriptions joint statement that was sent out by CPSS, CRNS, CLPNS and SCPP. Legislation requirements were included in the original joint statement. This second joint statement has been issued to provide further clarity regarding the use of verbal/telephone orders to dispense a prescription in a Long-Term Care (LTC) setting.

Pharmacists

  • Must receive orders to dispense a prescription directly from a physician, NP, RN (AAP), dentist and other authorized prescribers.
  • May accept a verbal/phone or faxed original prescription written and signed by an authorized prescriber.
  • May receive a faxed transcribed order from a nurse as a means of communication so the pharmacist can expect an order from the authorized prescriber and alerts the pharmacist to follow up with the prescriber if the prescription is not received.

Physicians

  • May provide nurses with a telephone/verbal order to facilitate timely patient care.
  • Must provide pharmacists with an order directly to authorize the pharmacist to dispense a prescription.

Nurses

  • May take telephone/verbal orders from an authorized prescriber and may fax the transcribed order to the pharmacist for communication purposes.
  • Cannot act as a third party in the direct communication required between the authorized prescriber and the pharmacist when there is an order to dispense a prescription.

CRNS Nursing Advisors are available to answer your questions. They can be contacted by phone at 1.800.667.9945 or 306.359.4227 or by email at practiceadvice@crns.ca.

NP Practice and the Radiology Information System (RIS)

Nurse Practitioners (NPs) provide excellent care in primary health care settings and a variety of specialized clinical contexts throughout Saskatchewan. CRNS has become aware of a clinical practice issue that is having negative impacts on patient outcomes and leading to potential patient privacy breaches due to misrouted medical imaging reports. Several of the identified causes are listed here:

  • Many NPs have more than one clinical site where they work. 
  • NPs may concurrently work within and outside of the SHA and order or request medical imaging studies for clients.
  • The CRNS database that verifies registration status of NPs does not contain clinic phone numbers, fax numbers or addresses. Therefore, it is not a resource that enables technologists to appropriately forward medical imaging reports.
  • The Radiology Information System (RIS) can only support one fax number per provider. Providers working at multiple sites must make arrangements with clinic staff at that site (the one with the distribution fax), to create a workflow so that the NP’s can receive their patient’s reports and booking notifications at any/all sites that they are providing patient care.
  • There are many different requisitions/ forms that are utilized when NPs order or request medical imaging studies in the various settings where they work.
  • Paper requisitions are not handled consistently by all SHA facilities. The SHA Medical Imaging Department cannot guarantee that the information on the requisition is translated through from request to finalization. The SHA Medical Imaging Department requires one fax for ALL reports and booking confirmations.

These factors can create barriers that lead to delays in care or privacy issues. CRNS is raising awareness of this issue and is recommending the following:

  • NPs ensure that clinic specific information is included on the medical imaging requisitions to enable more timely and accurate delivery of results to the appropriate location. 
  • NPs currently working only in one location may wish to ensure that their contact information is up to date.
  • NPs should update the RIS team each time they change their work location to ensure the best possible outcomes. 
  • NPs working in multiple sites should make arrangements with clinical staff to create a workflow to ensure that they are receiving all of their patient’s results in a timely manner.

Medical Assistance in Dying Guideline (2024)                 

The CRNS is pleased to announce the release of the updated Medical Assistance in Dying Guideline (2024). The Medical Assistance in Dying Guideline was approved by CRNS Council on February 23, 2024.

The guideline was updated to reflect best practices and standards as outlined in the nationally developed Model Practice Standard for Medical Assistance in Dying (MAID) and the Saskatchewan Health Authority (SHA) MAID program; Nurse Practitioner (NP) Entry-Level Competencies (ELC) were updated to the 2023 version; and the date in which people whose sole underlying medical condition is mental illness and wish to seek MAID was updated to reflect federal legislation and is March 17, 2027.

Reviewing this document will assist you in knowing the expectations of RN and NP practice in providing care to people seeking MAID. CRNS Practice Advisors are available to answer your questions. They can be contacted by phone at 1.800.667.9945 or 306.259.4227 or by email at practiceadvice@crns.ca.

Joint Statement: Long Term Care – Authorized Prescriptions                 

The SCPP, the CRNS, the CLPNS, and the CPSS have issued a joint statement regarding verbal orders generated from Long Term Care (LTC) Facilities. A pharmacist may only accept a verbal or faxed original order written and signed by an authorized prescriber e.g. physician, NP, dentist. A pharmacist may not accept a verbal or faxed written order (transcribed) from an RN. The full statement can be accessed here.

CRNS Nursing Advisors are available to answer your questions. They can be contacted by phone at 1.800.667.9945 or 306.359.4227 or by email at practiceadvice@crns.ca. 

Cervical Cancer Screening Updates

Cervical cancer screening in Saskatchewan recently changed when the revised cervical cancer screening clinical practice guidelines were updated in November 2023. Key changes to the new guidelines include:

  • Screening will start at age 25 or three years after becoming sexually active, whichever is later;
  • Routine screening will now be every three years until the age of 69; and,
  • The addition of Human Papillomavirus (HPV) reflex testing. 

These new evidence-based changes ensure people continue to benefit from screening while avoiding unnecessary tests and follow-up treatment. 

Click here to find information about the guidelines, including the new guidelines document. (link to: http://saskcancer.ca/health-professionals-article/cancer-screening-guidelines-and-resources/cervical-cancer-screening)

The SCA has collaborated with the Department of Obstetrics and Gynecology and the Division of Continuing Medical Education to create a free accredited course on the guidelines. The course will be available until July 2024. It can be found here. (link to: https://cmelearning.usask.ca/learn-here/cme-online-courses/cervical_cancer_guidelines_online-course.php)

If any questions arise about the guidelines, please feel free to reach out to the Screening Program for Cervical Cancer at ED.Coordinator@saskcancer.ca.

IV Hydration Therapy

The evolution of independent for-profit (stand-alone) clinics providing intravenous (IV) hydration therapy has prompted many calls to the CRNS. After completing environmental scanning and a review of best practices, the CRNS has determined that it is within the scope of practice of Registered Nurses (RN) to administer IV hydration therapy and medications, vitamins, and/or electrolytes (additives) while working in stand-alone clinics so long as the nursing process is implemented and appropriate policies and supports are in place to support safe, competent, and ethical care of this client population.  

RNs and Nurse Practitioners (NP) are accountable to practice within their legislated scope of practice and personal competence and to adhere to their Practice Standards and Code of Ethics as they would in any other practice setting.  Registrants must complete the Recognition of Practice process to use the title RN and/or NP and to count the practice hours they have worked in an IV hydration clinic towards licensure.

With the growing popularity of IV hydration therapy and individuals “self-selecting” treatments – for example, to relieve the effects of a hangover, there is an increasing trend of complaints related to unsafe practices and untoward events reported in Canada and the United States.  It is essential for RNs and NPs engaged in this practice to understand that IV hydration is a medical treatment and, therefore, there must be a medical condition for the client to obtain the treatment. As with all treatments and interventions, the risks of accepting treatments should be disclosed to the client and informed consent obtained.   

To provide safe, competent nursing care and to meet the requirements for Recognition of Practice, the following must be in place when performing IV hydration therapy treatments:

  1. Appropriate policies, procedures, and resources.
  2. A health history and physical examination must be performed and documented by the prescribing NP or physician to ascertain if underlying co-morbidities, such as congestive heart failure or kidney disease, might be a contraindication to the client receiving treatment.
  3. Provision for diagnostic testing, as indicated for co-morbidities, should be completed as part of the client assessment. Diagnostic testing should be considered to establish a baseline for ongoing treatment.
  4. The infusion must be prescribed to treat a diagnosed medical condition; clients must not “self-select” treatments. 
  5. There must be an order from an NP or physician for the RN to initiate the IV and/or administer the IV solution and additives.
  6. There must be appropriate documentation, including the client assessment, client consent, treatment ordered and administered, and client response to that treatment.
  7. The supplies, including IV lines, solution, and additives, must be procured from a reputable source and stored and handled in alignment with current infection prevention and control (IPAC) best practices and principles. 
  8. There must be an ability to manage untoward events, including having the necessary emergency equipment on site.

For more information or to inquire about recognition of practice, please contact a nursing practice advisor practiceadvice@crns.ca.

NPs Enabled to Order or Request Medical Imaging

In the 2022 updated regulatory bylaws that were approved and published in the September 9, 2022, Saskatchewan Gazette and came into effect on November 1, 2022, it included an update to Bylaw VI Categories of Practice, Section 3 Nurse Practitioner Category, which enables NPs to order or request medical imaging. This involves the application or detection of forms of energy for diagnostic and screening purposes and to receive and interpret reports, or to perform ultrasound imaging for the sole purpose of point-of-care diagnostic assistance when it is in the best interest of the client, in accordance with their practice standards and code of ethics, when they have the competence and judgment to safely do so, when it is in alignment with best practice evidence and when agency policy permits.

In our work to facilitate RNs and NPs practicing to their full scope, we’ve worked with the Saskatchewan Health Authority (SHA) to minimize disruptions and fully support NPs with equal opportunity to order diagnostic imaging exams SHA provides to General Practitioners (GP).

This allows access to almost all diagnostic testing services.

For MRI and PET/CT exams, NPs and GPs may require additional documentation of approval following a discussion with a radiologist, or a recommendation for such an exam in a previous medical imaging diagnostic report.

If an NP is experiencing challenges ordering diagnostic imaging, please get in touch with Jordan Vercaigne, Manager of Provincial Diagnostic Imaging Standards and Operations, at 306.491.8220.

Amendment to the Controlled Drugs and Substances Act & the Narcotic Control Regulations

Effective March 31, 2022, tramadol will be removed from the Prescription Drug List (PDL) and listed in Schedule 1 of the Controlled Drugs and Substances Act (CDSA). Tramadol will also be listed as item 19 in the Schedule of the Narcotic Control Regulations (NCR). This means that tramadol will be subject to all the regulatory requirements set out in the CDSA and NCR. The rational to change the listing is to reduce risks to human health, and to facilitate the detection and prevention of diversion of tramadol.

For a full explanation, including impact to practice, please visit:

https://gazette.gc.ca/rp-pr/p2/2021/2021-03-31/html/sor-dors43-eng.html

If you have any question about your NP practice, please contact practicadvice@crns.ca.  If you have any questions about prescribing controlled drugs and substances or the CRNS

Prescription Review Program, please contact prp@crns.ca

Posts navigation

1 2 3
Scroll to top
X